PrimeRFP SCOUT · Federal Contract Recompete Brief

15B20324F00000021Regular medication — Mckesson Corp

Mckesson Corp holds $32.0B across 6,790 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent VA797P12D0001. PoP ended Dec 3, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fci Danbury

Awarding office

Mckesson Corp

Recipient

Dec 3, 2025

PoP end

$1.4M

Obligated

$1.4M

Potential

325412

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Mckesson Corp — $90

Contract facts

Federal

Contract number15B20324F00000021

Also listed asVA797P12D0001-15B20324F00000021

AgencyFci Danbury

Awarding officeFci Danbury

Awarding agencyDepartment of Justice (DOJ)

Funding agencyDepartment of Justice (DOJ)

IncumbentMckesson Corp

CAGE1MKG3

UEIS1RUKWWRYFL6

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVVA797P12D0001

Place of performanceIRVING TX

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startJan 17, 2024

PoP end (current)Dec 3, 2025

Obligated$1.4M

Current value$1.4M

Potential value$1.4M

REGULAR MEDICATION. is a federal award for Fci Danbury held by Mckesson Corp. Estimated value $1.4M ($1.4M obligated). Current period of performance ends Dec 3, 2025. Place of performance: IRVING TX.

Recompete timing

Public

● Past PoP end (261 days ago)

Current PoP ended Dec 3, 2025 (261 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Mckesson Corp — $32.0B obligated across 6,790 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($32.0B) · all agencies

Department of Veterans Affairs (VA)$30.8B · 96%Department of Justice (DOJ)$617.6M · 2%Department of Health and Human Services (HHS)$535.6M · 2%Department of Homeland Security (DHS)$9.3M · 0%

Open full company profile →

Related awards

Same parent · incumbent

75H71025F26077

PHARMACEUTICAL SUPPLIES FOR TOHATCHI HEALTH CENTER

$127K

Aug 22, 2026

75H71225F28067

BPA CALL AGAINST MCKESSON IHS BPA # 75H71122A00161 FOR OPEN MARKET PHARMACEUTICAL PRODUCTS…

$249K

Aug 23, 2026

15B30226F00000093

MCKESSON REGULAR MEDICATION AUGUST 2026 FISCAL YEAR 2026 RP#: 0167-26

$600K

Aug 31, 2026

15B31426F00000053

B1- FY26 MCKESSON CONTRACT MEDICATION

$495K

Aug 31, 2026

15B41426F00000265

FY26 B1 MCKESSON B12648613F MEDS AUG 26

$275K

Aug 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 15B20324F00000021?

15B20324F00000021 (Regular medication) is a Fci Danbury award with a potential value of $1.4M, currently held by Mckesson Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 15B20324F00000021?

Fci Danbury awarded 15B20324F00000021 to Mckesson Corp (potential $1.4M).

Who is the incumbent on 15B20324F00000021?

Mckesson Corp is the incumbent with $32.0B across 6790 related awards in SCOUT’s public footprint. The current period of performance ends Dec 3, 2025.

When does Mckesson Corp’s 15B20324F00000021 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 3, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Dec 3, 2025